PD-L1 (+) was defined as the proportion of positive cells >30%, and PD-1 (+) was defined as the proportion of positive cells >5%; PD-1 (+) in tumor tissues of cHL patients was 10 cases (77%); 9 cases of PD-L1 (+), accounting for 69%. This evidence concerns the gene PDCD1 and neoplasm.